COMBINATION OF CBP/CATENIN INHIBITOR AND IMMUNE CHECKPOINT INHIBITOR FOR TREATING CANCER

The purpose of the present invention is to provide a cancer treatment drug having excellent therapeutic effect. The present invention combines a CBP/catenin inhibitor and an immune checkpoint inhibitor for treating cancer, and, as a result, not only the therapeutic effect against cancer is increased...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	OZAWA, YOICHI, ODAGAMI, TAKENAO, HORI, YUSAKU, KOUJI, HIROYUKI
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The purpose of the present invention is to provide a cancer treatment drug having excellent therapeutic effect. The present invention combines a CBP/catenin inhibitor and an immune checkpoint inhibitor for treating cancer, and, as a result, not only the therapeutic effect against cancer is increased but treatment can be also effectively performed on patients with cancer less susceptible to the immune checkpoint inhibitor alone. La présente invention vise à fournir un médicament anticancéreux ayant un excellent effet thérapeutique. La présente invention associe un inhibiteur de CBP/caténine et un inhibiteur du point de contrôle immunitaire pour le traitement d'un cancer, ce qui permet non seulement d'accroître l'effet antinéoplasique du traitement mais aussi d'être administré avec efficacité chez des patients atteints d'un cancer moins sensible à l'inhibiteur du point de contrôle immunitaire seul.